| Net Cash Provided by (Used in) Operating Activities |
-528K |
USD |
+5.38% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
200K |
USD |
|
Q4 2023 |
Q1 2025 |
| Common Stock, Shares Authorized |
300M |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
65.8M |
shares |
+23.6% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-528K |
USD |
-47.5% |
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.56M |
USD |
+425% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
13M |
USD |
+3.68% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
13M |
USD |
+3.68% |
Q3 2025 |
FY 2025 |
| Depreciation |
1.65K |
USD |
-54.2% |
Q4 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-2.26M |
USD |
+34.6% |
Q3 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
187K |
USD |
+25.2% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
9.63M |
USD |
+5.84% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
87.5M |
USD |
+4.71% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
1.56K |
USD |
+87.6% |
Q3 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
51.6K |
USD |
+122% |
Q4 2024 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |